vs

Side-by-side financial comparison of AMBARELLA INC (AMBA) and ANAPTYSBIO, INC (ANAB). Click either name above to swap in a different company.

AMBARELLA INC is the larger business by last-quarter revenue ($108.5M vs $108.2M, roughly 1.0× ANAPTYSBIO, INC). ANAPTYSBIO, INC runs the higher net margin — 45.8% vs -13.9%, a 59.8% gap on every dollar of revenue. On growth, ANAPTYSBIO, INC posted the faster year-over-year revenue change (151.1% vs 31.2%). ANAPTYSBIO, INC produced more free cash flow last quarter ($98.0M vs $31.4M). Over the past eight quarters, ANAPTYSBIO, INC's revenue compounded faster (288.3% CAGR vs 45.0%).

Ambarella, Inc. is an American fabless semiconductor design company, focusing on low-power, high-definition (HD) and Ultra HD video compression, image processing, and computer vision processors. Ambarella's products are used in a wide variety of human and computer vision applications, including video security, advanced driver assistance systems (ADAS), electronic mirror, drive recorder, driver and in-cabin monitoring, autonomous driving, and robotics applications. Ambarella's system on chips ...

AnaptysBio, Inc. is a clinical-stage biotechnology company focused on developing antibody-based immunotherapies for inflammatory diseases, immuno-oncology indications, and rare disease conditions. It primarily serves the U.S. market, advancing its innovative product candidate pipeline to address unmet medical needs via rigorous research and clinical development.

AMBA vs ANAB — Head-to-Head

Bigger by revenue
AMBA
AMBA
1.0× larger
AMBA
$108.5M
$108.2M
ANAB
Growing faster (revenue YoY)
ANAB
ANAB
+119.9% gap
ANAB
151.1%
31.2%
AMBA
Higher net margin
ANAB
ANAB
59.8% more per $
ANAB
45.8%
-13.9%
AMBA
More free cash flow
ANAB
ANAB
$66.6M more FCF
ANAB
$98.0M
$31.4M
AMBA
Faster 2-yr revenue CAGR
ANAB
ANAB
Annualised
ANAB
288.3%
45.0%
AMBA

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
AMBA
AMBA
ANAB
ANAB
Revenue
$108.5M
$108.2M
Net Profit
$-15.1M
$49.6M
Gross Margin
59.6%
Operating Margin
-15.0%
61.8%
Net Margin
-13.9%
45.8%
Revenue YoY
31.2%
151.1%
Net Profit YoY
37.2%
327.8%
EPS (diluted)
$-0.35
$1.64

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMBA
AMBA
ANAB
ANAB
Q4 25
$108.5M
$108.2M
Q3 25
$95.5M
$76.3M
Q2 25
$85.9M
$22.3M
Q1 25
$84.0M
$27.8M
Q4 24
$82.7M
$43.1M
Q3 24
$63.7M
$30.0M
Q2 24
$54.5M
$11.0M
Q1 24
$51.6M
$7.2M
Net Profit
AMBA
AMBA
ANAB
ANAB
Q4 25
$-15.1M
$49.6M
Q3 25
$-20.0M
$15.1M
Q2 25
$-24.3M
$-38.6M
Q1 25
$-20.2M
$-39.3M
Q4 24
$-24.1M
$-21.8M
Q3 24
$-34.9M
$-32.9M
Q2 24
$-37.9M
$-46.7M
Q1 24
$-60.6M
$-43.9M
Gross Margin
AMBA
AMBA
ANAB
ANAB
Q4 25
59.6%
Q3 25
58.9%
Q2 25
60.0%
Q1 25
60.0%
Q4 24
60.6%
Q3 24
60.8%
Q2 24
60.9%
Q1 24
59.8%
Operating Margin
AMBA
AMBA
ANAB
ANAB
Q4 25
-15.0%
61.8%
Q3 25
-23.0%
45.5%
Q2 25
-30.1%
-117.5%
Q1 25
-30.2%
-99.2%
Q4 24
-30.9%
-22.4%
Q3 24
-56.9%
-75.8%
Q2 24
-72.4%
-367.5%
Q1 24
-80.8%
-587.8%
Net Margin
AMBA
AMBA
ANAB
ANAB
Q4 25
-13.9%
45.8%
Q3 25
-20.9%
19.8%
Q2 25
-28.3%
-173.5%
Q1 25
-24.1%
-141.6%
Q4 24
-29.1%
-50.5%
Q3 24
-54.8%
-109.4%
Q2 24
-69.6%
-425.3%
Q1 24
-117.4%
-612.0%
EPS (diluted)
AMBA
AMBA
ANAB
ANAB
Q4 25
$-0.35
$1.64
Q3 25
$-0.47
$0.52
Q2 25
$-0.58
$-1.34
Q1 25
$-0.48
$-1.28
Q4 24
$-0.58
$-0.63
Q3 24
$-0.85
$-1.14
Q2 24
$-0.93
$-1.71
Q1 24
$-1.51
$-1.64

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMBA
AMBA
ANAB
ANAB
Cash + ST InvestmentsLiquidity on hand
$174.1M
$238.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$590.1M
$37.2M
Total Assets
$751.9M
$364.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMBA
AMBA
ANAB
ANAB
Q4 25
$174.1M
$238.2M
Q3 25
$142.7M
$109.8M
Q2 25
$141.3M
$44.3M
Q1 25
$144.6M
$98.6M
Q4 24
$127.1M
$123.1M
Q3 24
$153.9M
$191.6M
Q2 24
$131.8M
$71.8M
Q1 24
$144.9M
$53.7M
Stockholders' Equity
AMBA
AMBA
ANAB
ANAB
Q4 25
$590.1M
$37.2M
Q3 25
$576.5M
$-29.4M
Q2 25
$572.7M
$-44.7M
Q1 25
$561.4M
$34.0M
Q4 24
$554.3M
$70.9M
Q3 24
$547.6M
$84.4M
Q2 24
$555.4M
$9.9M
Q1 24
$559.9M
$47.8M
Total Assets
AMBA
AMBA
ANAB
ANAB
Q4 25
$751.9M
$364.4M
Q3 25
$706.4M
$353.1M
Q2 25
$701.9M
$335.3M
Q1 25
$689.0M
$422.1M
Q4 24
$670.8M
$483.8M
Q3 24
$650.3M
$493.4M
Q2 24
$638.7M
$427.4M
Q1 24
$657.7M
$405.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMBA
AMBA
ANAB
ANAB
Operating Cash FlowLast quarter
$34.3M
$98.0M
Free Cash FlowOCF − Capex
$31.4M
$98.0M
FCF MarginFCF / Revenue
29.0%
90.5%
Capex IntensityCapex / Revenue
2.7%
0.0%
Cash ConversionOCF / Net Profit
1.98×
TTM Free Cash FlowTrailing 4 quarters
$64.3M
$19.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMBA
AMBA
ANAB
ANAB
Q4 25
$34.3M
$98.0M
Q3 25
$5.5M
$-27.4M
Q2 25
$14.8M
$-40.2M
Q1 25
$25.4M
$-10.7M
Q4 24
$6.6M
$-66.7M
Q3 24
$16.7M
$-10.1M
Q2 24
$-15.0M
$-21.3M
Q1 24
$-4.0M
$-37.3M
Free Cash Flow
AMBA
AMBA
ANAB
ANAB
Q4 25
$31.4M
$98.0M
Q3 25
$1.4M
$-27.4M
Q2 25
$10.2M
$-40.3M
Q1 25
$21.2M
$-10.7M
Q4 24
$4.1M
$-66.9M
Q3 24
$14.2M
$-10.1M
Q2 24
$-16.1M
$-21.4M
Q1 24
$-6.0M
$-37.3M
FCF Margin
AMBA
AMBA
ANAB
ANAB
Q4 25
29.0%
90.5%
Q3 25
1.4%
-35.9%
Q2 25
11.9%
-180.9%
Q1 25
25.3%
-38.7%
Q4 24
5.0%
-155.3%
Q3 24
22.2%
-33.7%
Q2 24
-29.5%
-194.6%
Q1 24
-11.6%
-519.3%
Capex Intensity
AMBA
AMBA
ANAB
ANAB
Q4 25
2.7%
0.0%
Q3 25
4.3%
0.0%
Q2 25
5.3%
0.2%
Q1 25
5.0%
0.1%
Q4 24
3.0%
0.6%
Q3 24
4.0%
0.1%
Q2 24
2.1%
0.3%
Q1 24
3.7%
0.4%
Cash Conversion
AMBA
AMBA
ANAB
ANAB
Q4 25
1.98×
Q3 25
-1.81×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AMBA
AMBA

TW$76.0M70%
Asia Pacific Other Than Taiwan$20.2M19%
North America Other Than United States$7.4M7%
Other$5.0M5%

ANAB
ANAB

Segment breakdown not available.

Related Comparisons